Recombinant human Erythropoietin enhanced the cytotoxic effects of tamoxifen toward the spheroid MCF-7 breast cancer cells

Erythropoietin (EPO) is widely used to treat anemia in patients undergoing chemotherapy for cancers. The main objective of this study was to investigate the effect of rHuEPO on the response of spheroid breast cancer, MCF-7, cells to tamoxifen treatment. The MCF-7 spheroids were treated with 10 mg/mL...

Descripción completa

Detalles Bibliográficos
Autores principales: Shujaa Edin, Hareth Y., AL-Haj, Nagi A., Rasedee, Abdullah, Banu Alitheen, Noorjahan, Abdul Kadir, Arifah, Wun How, Chee, Sulaiman Rahman, Heshu, AL-Shwyeh, Hussah Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381065/
https://www.ncbi.nlm.nih.gov/pubmed/34466099
http://dx.doi.org/10.1016/j.sjbs.2021.05.043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381065/
https://www.ncbi.nlm.nih.gov/pubmed/34466099
http://dx.doi.org/10.1016/j.sjbs.2021.05.043

Ejemplares similares